The evidence for fungus in Crohn’s disease pathogenesis

Jun Miyoshi, Mark Anthony Sofia, Joseph Pierre

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Current evidence suggests the etiology of inflammatory bowel diseases (IBD) involves the confluence of host genetic, environmental, and microbial factors that lead to chronic, and often refractory, disease in susceptible individuals. The involvement of microbial triggers in IBD, including Crohn’s disease (CD), is increasingly evident with supporting data provided with advancements in metagenomic sequencing that have identified perturbations in microbial structure and function—broadly termed dysbiosis—in CD patients compared with healthy subjects. This concept is supported by the finding germ-free animals with CD genetic susceptibility fail to develop disease; demonstrating microorganisms are necessary but not sufficient for CD. The vast majority of CD microbiome research has focused on the complex bacterial communities and microbiome dysbiosis in the gut with 16S metagenomic sequencing. However, emerging data capturing eukaryotes suggest fungal opportunistic pathogens are also associated with IBD pathogenesis and chronicity. This hypothesis is further supported by historical observations that CD patient populations display elevated antibodies against fungal targets, even evident before disease diagnosis. This review discusses the current findings in the field, followed by historical and metagenomic evidence for fungal pathogens in the development and recurrence of CD in adult and pediatric populations.

Original languageEnglish (US)
Pages (from-to)449-456
Number of pages8
JournalClinical Journal of Gastroenterology
Volume11
Issue number6
DOIs
StatePublished - Dec 1 2018

Fingerprint

Crohn Disease
Fungi
Metagenomics
Inflammatory Bowel Diseases
Microbiota
Fungal Antibodies
Microbial Genetics
Dysbiosis
Disease Susceptibility
Genetic Predisposition to Disease
Eukaryota
Population
Healthy Volunteers
Pediatrics
Recurrence
Research

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

The evidence for fungus in Crohn’s disease pathogenesis. / Miyoshi, Jun; Sofia, Mark Anthony; Pierre, Joseph.

In: Clinical Journal of Gastroenterology, Vol. 11, No. 6, 01.12.2018, p. 449-456.

Research output: Contribution to journalReview article

Miyoshi, Jun ; Sofia, Mark Anthony ; Pierre, Joseph. / The evidence for fungus in Crohn’s disease pathogenesis. In: Clinical Journal of Gastroenterology. 2018 ; Vol. 11, No. 6. pp. 449-456.
@article{510a7a17863d4f79a23f7780f77fc5ef,
title = "The evidence for fungus in Crohn’s disease pathogenesis",
abstract = "Current evidence suggests the etiology of inflammatory bowel diseases (IBD) involves the confluence of host genetic, environmental, and microbial factors that lead to chronic, and often refractory, disease in susceptible individuals. The involvement of microbial triggers in IBD, including Crohn’s disease (CD), is increasingly evident with supporting data provided with advancements in metagenomic sequencing that have identified perturbations in microbial structure and function—broadly termed dysbiosis—in CD patients compared with healthy subjects. This concept is supported by the finding germ-free animals with CD genetic susceptibility fail to develop disease; demonstrating microorganisms are necessary but not sufficient for CD. The vast majority of CD microbiome research has focused on the complex bacterial communities and microbiome dysbiosis in the gut with 16S metagenomic sequencing. However, emerging data capturing eukaryotes suggest fungal opportunistic pathogens are also associated with IBD pathogenesis and chronicity. This hypothesis is further supported by historical observations that CD patient populations display elevated antibodies against fungal targets, even evident before disease diagnosis. This review discusses the current findings in the field, followed by historical and metagenomic evidence for fungal pathogens in the development and recurrence of CD in adult and pediatric populations.",
author = "Jun Miyoshi and Sofia, {Mark Anthony} and Joseph Pierre",
year = "2018",
month = "12",
day = "1",
doi = "10.1007/s12328-018-0886-9",
language = "English (US)",
volume = "11",
pages = "449--456",
journal = "Clinical Journal of Gastroenterology",
issn = "1865-7257",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - The evidence for fungus in Crohn’s disease pathogenesis

AU - Miyoshi, Jun

AU - Sofia, Mark Anthony

AU - Pierre, Joseph

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Current evidence suggests the etiology of inflammatory bowel diseases (IBD) involves the confluence of host genetic, environmental, and microbial factors that lead to chronic, and often refractory, disease in susceptible individuals. The involvement of microbial triggers in IBD, including Crohn’s disease (CD), is increasingly evident with supporting data provided with advancements in metagenomic sequencing that have identified perturbations in microbial structure and function—broadly termed dysbiosis—in CD patients compared with healthy subjects. This concept is supported by the finding germ-free animals with CD genetic susceptibility fail to develop disease; demonstrating microorganisms are necessary but not sufficient for CD. The vast majority of CD microbiome research has focused on the complex bacterial communities and microbiome dysbiosis in the gut with 16S metagenomic sequencing. However, emerging data capturing eukaryotes suggest fungal opportunistic pathogens are also associated with IBD pathogenesis and chronicity. This hypothesis is further supported by historical observations that CD patient populations display elevated antibodies against fungal targets, even evident before disease diagnosis. This review discusses the current findings in the field, followed by historical and metagenomic evidence for fungal pathogens in the development and recurrence of CD in adult and pediatric populations.

AB - Current evidence suggests the etiology of inflammatory bowel diseases (IBD) involves the confluence of host genetic, environmental, and microbial factors that lead to chronic, and often refractory, disease in susceptible individuals. The involvement of microbial triggers in IBD, including Crohn’s disease (CD), is increasingly evident with supporting data provided with advancements in metagenomic sequencing that have identified perturbations in microbial structure and function—broadly termed dysbiosis—in CD patients compared with healthy subjects. This concept is supported by the finding germ-free animals with CD genetic susceptibility fail to develop disease; demonstrating microorganisms are necessary but not sufficient for CD. The vast majority of CD microbiome research has focused on the complex bacterial communities and microbiome dysbiosis in the gut with 16S metagenomic sequencing. However, emerging data capturing eukaryotes suggest fungal opportunistic pathogens are also associated with IBD pathogenesis and chronicity. This hypothesis is further supported by historical observations that CD patient populations display elevated antibodies against fungal targets, even evident before disease diagnosis. This review discusses the current findings in the field, followed by historical and metagenomic evidence for fungal pathogens in the development and recurrence of CD in adult and pediatric populations.

UR - http://www.scopus.com/inward/record.url?scp=85050344017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050344017&partnerID=8YFLogxK

U2 - 10.1007/s12328-018-0886-9

DO - 10.1007/s12328-018-0886-9

M3 - Review article

VL - 11

SP - 449

EP - 456

JO - Clinical Journal of Gastroenterology

JF - Clinical Journal of Gastroenterology

SN - 1865-7257

IS - 6

ER -